UCLA is one of seven sites participating in a clinical trial investigating whether hydroxychloroquine, a commonly used anti-malarial and autoimmune drug, can prevent infection with COVID-19, it was announced Thursday. The multi-site study led by the University of Washington in collaboration with six other university centers, is now enrolling 2,000 participants who are close contacts […]